Involvement of phosphatidylinositol-3 kinase/AKT/PKCzeta/lambda pathway in the effect of palmitate on glucose-induced insulin secretion.
about
Therapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseNetwork-level effects of kinase inhibitors modulate TNF-α-induced apoptosis in the intestinal epitheliumMetabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseasesChronic alcohol-induced hepatic insulin resistance and endoplasmic reticulum stress ameliorated by peroxisome-proliferator activated receptor-δ agonist treatmentInsulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedCeramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis.Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's diseaseInsulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.Changes in food intake, metabolic parameters and insulin resistance are induced by an isoenergetic, medium-chain fatty acid diet and are associated with modifications in insulin signalling in isolated rat pancreatic islets.Induction of Stress Signaling In Vitro and Suppression of Gonadotropin Secretion by Free Fatty Acids in Female Mouse Gonadotropes.Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.
P2860
Q27021700-A77823F3-B288-401B-BEAF-5F493983BF75Q28259585-E5BCC42A-2551-4D11-8900-1B61E335B340Q28390885-90F7072B-D545-44C1-B7C9-346802685315Q34288447-92A69045-BEBD-47EB-A14B-8EB4A85A6759Q35527928-F384D19C-D620-4FF0-AB7E-35726B8FFEE4Q35944938-C0B4018B-C2C3-43BF-9AC3-EF601ADEECC5Q35997884-D1FA6D08-7724-4088-A026-1270A22B3E8EQ36001362-363B8AE7-7231-410E-B0BB-D14528DF0F36Q36036789-02B45ED1-B5C0-408A-9BB3-668876E12726Q36469896-E879F7A0-1D89-43DF-B6E4-130D560A82B0Q37335385-CB9E3962-E1B1-423F-BB27-9864757B488DQ37602608-B9ADFEA7-1959-41A5-BA6E-0CFE4006BCB7Q45943791-7D12BC40-FDD5-4213-9EA2-AD10F3FF9D27Q47556305-C2A93380-04F5-48AB-8731-1E0844317450Q52647109-35EA7D04-FF2F-4EE6-877A-C14E2E4C2BF5
P2860
Involvement of phosphatidylinositol-3 kinase/AKT/PKCzeta/lambda pathway in the effect of palmitate on glucose-induced insulin secretion.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Involvement of phosphatidylino ...... ose-induced insulin secretion.
@en
Involvement of phosphatidylino ...... ose-induced insulin secretion.
@nl
type
label
Involvement of phosphatidylino ...... ose-induced insulin secretion.
@en
Involvement of phosphatidylino ...... ose-induced insulin secretion.
@nl
prefLabel
Involvement of phosphatidylino ...... ose-induced insulin secretion.
@en
Involvement of phosphatidylino ...... ose-induced insulin secretion.
@nl
P2093
P50
P1433
P1476
Involvement of phosphatidylino ...... cose-induced insulin secretion
@en
P2093
Angelo R Carpinelli
Tatiane C A Nogueira
P304
P356
10.1097/MPA.0B013E318168DAC3
P577
2008-10-01T00:00:00Z